Judge Recommends Revoking Impax's Registration
An administrative law judge has recommended that the U.S. Securities and Exchange Commission suspend or revoke the registration of Impax Laboratories on the grounds that the pharmaceutical company has not filed...To view the full article, register now.
Already a subscriber? Click here to view full article